Multicomponent Therapeutics of Berberine Alkaloids
Figure 2
Schematic diagram of 36-point dose matrices for two-component combination assay. The five test concentrations for each compound were chosen by first determining the EC50 of each compound as a single agent in this assay, and then selecting 4-fold and 16-fold higher and lower concentrations.